TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $34.66M2014: $111.00M2015: $142.94M2016: $300.22M2017: $364.25M2018: $996.54M2019: $771.20M2020: $644.14M2021: $529.35M2022: $356.05M2023: $241.70M2024: $220.67M2025: $376.56M$376.56M
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$376.56M+70.6%
2024$220.67M-8.7%
2023$241.70M-32.1%
2022$356.05M-32.7%
2021$529.35M-17.8%
2020$644.14M-16.5%
2019$771.20M-22.6%
2018$996.54M+173.6%
2017$364.25M+21.3%
2016$300.22M+110.0%
2015$142.94M+28.8%
2014$111.00M+220.2%
2013$34.66M—